key: cord-0706797-u29a2u5k authors: Erşan, Sevcan; Park, Junyoung O. title: Light-Independent Biological Conversion of CO(2) date: 2020-09-07 journal: Joule DOI: 10.1016/j.joule.2020.08.007 sha: 67743275a49dcdcb166a64aeb878cb7a6cf0cd06 doc_id: 706797 cord_uid: u29a2u5k Sevcan Erşan is a postdoctoral researcher at UCLA. Previously, she conducted postdoctoral research at the University of Hohenheim in Germany. She received her PhD in biotechnology from Yeditepe University, Turkey, and her bachelor’s and master’s degrees in food engineering from Istanbul Technical University, Turkey. She is experienced in waste utilization, bioprocessing technologies, and biological activities associated with phytochemicals. Her current research focuses on natural product chemistry and sustainable biotechnology. [Figure: see text] Junyoung Park is an assistant professor of Chemical and Biomolecular Engineering and co-director of the Metabolomics Center at UCLA. His research group focuses on systems-level analysis of metabolic networks to elucidate regulatory mechanisms and engineer metabolism. He aims to apply this knowledge to solving energy and environmental problems and curing human diseases such as cancer and diabetes. Before moving to Los Angeles, he conducted postdoctoral research at MIT. He received his bachelor’s degrees in mathematics and bioengineering from UC San Diego and a master’s and PhD in chemical engineering from Princeton University. [Figure: see text] Sevcan Ers xan is a postdoctoral researcher at UCLA. Previously, she conducted postdoctoral research at the University of Hohenheim in Germany. She received her PhD in biotechnology from Yeditepe University, Turkey, and her bachelor's and master's degrees in food engineering from Istanbul Technical University, Turkey. She is experienced in waste utilization, bioprocessing technologies, and biological activities associated with phytochemicals. Her current research focuses on natural product chemistry and sustainable biotechnology. Junyoung Park is an assistant professor of Chemical and Biomolecular Engineering and co-director of the Metabolomics Center at UCLA. His research group focuses on systems-level analysis of metabolic networks to elucidate regulatory mechanisms and engineer metabolism. He aims to apply this knowledge to solving energy and environmental problems and curing human diseases such as cancer and diabetes. Before moving to Los Angeles, he conducted postdoctoral research at MIT. He received his bachelor's degrees in mathematics and bioengineering from UC San Diego and a master's and PhD in chemical engineering from Princeton University. A growing concern of 21 st -century humanity is the continuing rise of atmospheric CO 2 levels from expanded use of fossil fuels for heat and power generation. Each day that CO 2 levels rise, humanity treads further into the uncharted waters of a changing climate and ecosystem. Mitigating carbon emissions is only a transitory solution to relieving uncertainty in the future environmental impacts. To be able to control atmospheric CO 2 levels, capabilities to net remove CO 2 -in other words, ''negative emissions'' technologiesare a must. Various carbon capture, utilization, and storage (CCUS) approaches are underway to remedy the imbalance between CO 2 generation and absorption. Strategies to convert CO 2 into value-added products are particularly appealing because of potential environmental and economic benefits. In practice, achieving CO 2 utilization profitably is a grand challenge. Effective CO 2 utilization strategies must be able to stand the test of time. Recent US oil prices have been hovering around $30-$40 per barrel, and as states went into lockdown due to coronavirus disease 2019 (COVID-19), the price turned negative for the first time in history, albeit briefly. A business that converts CO 2 into fuel to sell it would struggle to survive in today's world of cheap oil. Likewise, few things are of lasting value, and thus a stable CO 2 removal program demands a flexible product lineup. What are the key features of enduring technologies that can weather geopolitical and economic turbulence? In addition to high concentration, purity, scalability, and productivity, a diversifiable product repertoire is needed. Biological conversion of CO 2 may fit the bill. Most of us naturally associate biological CO 2 conversion with photosynthesis in plants and algae. While engineering photosynthetic hosts to convert CO 2 into high-value products is sensible, dependence on sunlight limits its tractability and scalability. The productivity of photosynthesis is proportional to the surface area exposed to sunlight, a capricious source of energy in many regions. Furthermore, the maximum efficiency of solar energy conversion by photosynthesis is 5%, while typical solar panel efficiency reaches 20%. These shortcomings may be overcome if the Calvin cycle-the light-independent metabolic pathway in which CO 2 is assimilated by the famous enzyme Rubiscois introduced into non-photosynthetic organisms and driven by chemical energy instead of light. 1 Perhaps less familiar to most is a biological yet non-photosynthetic CO 2 reduction mechanism: the reductive acetyl-CoA pathway, also known as the Wood-Ljungdahl pathway (WLP). Acetogenic microbes (e.g., A. woodii, C. ljungdahlii, and M. thermoacetica) can reduce two CO 2 molecules, via the carbonyl and methyl branches of this pathway, to make one acetic acid (Figure 1 ). 2 Unlike plants and algae, these acetogens do not depend on sunlight; they can instead derive energy from H 2 (Reaction 1). 2 CO 2 + 4 H 2 + x ADP + x P i / CH 3 COOH + (2+x) H 2 O + x ATP (Reaction 1) x varies between 0 and 1 depending on organisms and conditions because ATP is generated by chemiosmosis (the transport of H + or Na + down their electrochemical gradients). As the WLP includes thermodynamically challenging steps, cells use an energy-efficient means of transferring electrons, termed electron bifurcation. 3 An example is the hydrogenase enzyme that transfers electrons from H 2 to two electron carriers (Reaction 2): (1) ferredoxin (Fd), an iron-sulfur protein family with more negative reduction potential to overcome the reduction energy barrier and (2) NAD + , with less negative reduction potential to limit wasting free energy. Some electron transfer steps involving transmembrane proteins (e.g., Ech and Rnf complexes) are linked to creating an electrochemical gradient by pumping out H + (or Na + in A. woodii) across the cytoplasmic membrane. ATP synthase then uses the proton motive force, the flow of H + back into the cytoplasm, to drive ATP synthesis (Reaction 3). Fd 2-+ 2 H + (or NAD + + H + ) + x ADP + x P i / Fd + H 2 (or NADH) + x Acetogens can extract usable energy from various sources: gases (Reactions 1 and 4), organic molecules (Reaction 5), and electricity (Reactions 3 and 6). This versatility in energy utilization allows CO 2 conversion via mixotrophic fermentation 4 (e.g., simultaneously using Reactions 1, 4, and 5) and microbial electrosynthesis 5 (i.e., using Reactions 3 and 6 to obtain reducing power and ATP to convert CO 2 and sustain necessary cellular functions). An inevitable challenge associated with biological CO 2 conversion is that typical bioprocesses are slow and must be sped up. This complication arises because cells require energy in two forms, reducing power and ATP, in balance. For acetogens, which are obligate anaerobes unable to use aerobic respiration with its associated potent oxidizing agent O 2 , converting redox potential to ATP is a challenging task (Reaction 3). ATP is not only required for maintenance of essential cellular functions for survival, but it also drives otherwise thermodynamically unfavorable reactions by hydrolyzing its high-energy phosphoanhydride bond for biosynthesis. Therefore, metabolic engineers must ensure that (1) minimum cellular ATP requirement is met and (2) O Further converted to advanced products via microbes in co-culture or two-stage reactor systems The reductive acetyl-CoA pathway, also known as the Wood-Ljungdahl pathway (WLP), converts two CO 2 molecules, via the methyl and the carbonyl branches, into one acetic acid. The one-carbon units in the methyl branch are bound to and carried by tetrahydrofolate (not depicted). The CO 2derived acetic acid can be fed to other microbes for synthesis of more advanced products. ll reduce 56 g of CO 2 per day, 50 times as fast as photosynthetic cells). 6 How is non-photosynthetic CO 2 utilization beneficial? One major benefit is that, in addition to having a relatively high specific productivity, this approach scales up volumetrically, not areally, due to its independence from sunlight (Figure 2) . Furthermore, while the product of CO 2 assimilation, acetic acid, does not itself have a high market value, it can support both microbial cell division and biosynthesis of more valuable molecules. When provided as a substrate to other microbes, acetic acid derived from CO 2 may yield various biomolecules including fatty acids, polyketides, and isoprenoids. The depth of potential bioproduct diversity from CO 2 , with the advancement of synthetic biology and diverse genetic materials found in the kingdoms of life, is nearly unfathomable. Converting CO 2 into secondary metabolites-via co-culture or two-stage reactor systems-is an exciting opportunity because of their antimicrobial, anti-inflammatory, antioxidant, and other diverse biological activities. Since the discovery of penicillin, antibiotics have been among the bestknown microbial secondary metabolites, which are non-essential for cell growth but useful in coping with environmental stressors and facilitating symbiosis. Secondary metabolites encompass alkaloids, aromatic compounds, isoprenoids, oligosaccharides, nonribosomal peptides, and polyketides, which are of use in pharma-ceutical, cosmetic, food, agricultural, and chemical industries as drugs, UV filters, plant growth regulators, insecticides, etc. This market diversity is a hedge against future volatility-for example, as a way to make up for low profitability of biojet fuel and biodiesel in a world of cheap oil. From an economic perspective, the cost of goods sold (COGS) and product prices determine which CO 2 utilization strategies are worthwhile. The cost of CO 2 varies considerably depending on the proximity of CO 2 capture plants to CO 2 generating plants. Direct air capture currently costs $700 to remove one metric ton of CO 2 , 7 but the cost would be substantially lower if more concentrated CO 2 is captured at the source before being released into the atmosphere. For example, the flue gases from coal and natural gas power plants, as well as ethanol plants, would provide ''cheap'' CO 2 if directly passed on to CO 2 utilization plants. Subsequently, CO 2 conversion should be carried out in cost-effective processes. Bioprocesses offer cost-effective solutions, especially for synthesis of large or complex molecules. That is because the catalysts-which in non-biological processes, are often a major expense-are cells that self-replicate rapidly. Furthermore, cells can be genetically modified to be equipped with various biosynthetic pathways without additional capital expenditure. This in turn provides bioprocesses with the benefit of relatively low facility-dependent costs such as depreciation and amortization (the direct fixed capital of a plant with a 500 m 3 bioreactor capacity, which can remove 200 metric tons of CO 2 per day, is $200 million). Instead of relying on traditional batch-culture systems, utilizing continuous bioprocessing may lower operating expenditure and COGS. Other important determinants of unit production costs via non-photosynthetic bioprocesses are the cost of energy (electricity and H 2 ) and the cost incurred by downstream processing-which comprises as much as 80% of manufacturing costs and depends on product concentration and purity, as well as production scale. Today, electrical energy is generally more cost effective than H 2 . In California, the retail energy prices are $0.05/MJ for electricity ($0.20/kWh) and $0.12/MJ for H 2 (using 120 MJ/ kg, lower heating value). H 2 is $14/kg at a hydrogen fueling station, although H 2 production by electrolysis would cost $11/kg with some additional costs expected due to pressurization and distribution. In some regions, however, renewable H 2 price may be as low as $3.50/kg. 8 H 2 is even cheaper (as low as $1/kg) from large-scale fossil hydrogen supply. While not ideal, even H 2 derived from methane could still enable net CO 2 removal. Via steam methane reforming and water-gas shift reaction, each methane produces one CO 2 and four H 2 , which can be used to convert two CO 2 into one acetic acid, a starting substrate for any biomolecule. As these processes require heating and cooling, the actual net CO 2 that can be reduced via the WLP per methane would be lower (0.1 net CO 2 removed per CH 4 ). Of course, the full CO 2 utilization potential is realized when the energy requirement is through clean zero-emission sources. Despite these energy prices, producing high-value chemicals may render nonphotosynthetic bioprocesses economically viable, while producing lower-value products faces headwinds. Since H 2 delivers electrons directly to cellular molecules and contributes to biosynthesis stoichiometrically while Faraday efficiency in microbial electrosynthesis is not well established, here the focus will be on renewable H 2 . Using H 2 at $3.50/kg to convert CO 2 into acetic acid-one of the simplest products made by nonphotosynthetic CO 2 conversion-corresponds to $0.50 worth of H 2 to produce (without taking into consideration fermentation and purification costs) one kg of acetic acid whose market price is $0.60/kg. The CO 2 -derived acetic acid can be directly fed to other microbes for advanced product synthesis. The economic challenge lingers if producing, for example, biofuel, which requires combining several acetic acids, when producing one kg of biofuel costs >$3, yet crude oil is $0.25/kg ($34/barrel). However, if the targets were b-carotene and paclitaxel, which respectively are $1,000/kg and $1,000,000/kg, 9 the CO 2 conversion processes would make sense-but not without challenges. Besides the total addressable market being smaller than the fuels market, one key challenge to overcome in secondary metabolite production is low product concentration. For instance, b-carotene, a tetraterpenoid with health benefits that is produced by engineered Y. lipolytica via the mevalonate pathway, currently reaches the titer of 6.5 g/L. 10 Furthermore, the great diversity of chemical structures, reaction mechanisms, and genetic origins presents important hurdles for chemists and metabolic engineers. Discovering nature's chemical toolset would unlock more opportunities. 11 The advancement of modern genetic and analytical tools, as well as integrative omic approaches, would facilitate these efforts. Economic and global-scale CO 2 utilization requires multidisciplinary teams of scientists and engineers. While the high specificity of enzymes-owed to discriminatory and stereospecific recognition of substrates-is a key ingredient for successful CO 2 utilization, the full potential of CO 2 utilization will only be realized by integrating biological and inorganic catalysis. The biochemical part of the team should strive to rapidly produce complex chemicals at high purity and concentration starting from acetic acid (past metabolic engineering efforts have focused on utilizing mainly glucose). With the goal of integrating with the former, the abiological counterpart should strive to maximize gas and electron transfer rate to cells and efficiently purify the products. To maximize net CO 2 utilization, further research into securing low-carbon energy at a low cost is needed. Solving these challenges will allow CO 2derived products to enter more markets (including the fuels market) more competitively. These are not insurmountable challenges. Technological advances have been driving renewable energy costs lower. CO 2 utilization processes could perhaps use H 2 generated using the intermittent surplus energy in the electricity market. The unique strengths of biological and inorganic catalysis may be combined by using non-photosynthetic microbes that are amenable to integration with inorganic processes. 12 Formic acid and CO, which can be readily produced electrochemically and provide carbon and energy to microbes, would serve as good intermediary molecules. Furthermore, CO 2 -derived products may be Figure 3 . The Overall Schema for Non-photosynthetic CO 2 Utilization toward a Sustainable Future Using various sources of energy and integrated biological-inorganic catalysis may optimize non-photosynthetic CO 2 conversion. Producing both highmargin products and high-volume products will ensure economic and global-scale CO 2 utilization. ll strategically developed to utilize existing infrastructures (e.g., oil infrastructure for refining, distributing, and storing biofuels). Developing technologies to convert CO 2 into both high-margin products and high-volume products would ensure a positive global impact ( Figure 3 ). In the near future, it will be possible to kill two birds (attain environmental and economic benefits) with one stone. Until then, rigorous technoeconomic analysis and life cycle assessment should be carried out for any promising technologies. The processes should be designed to withstand the constant pressure for lower price. With their evolutionarily crafted efficiency, microbes that have once contributed to rendering our primordial planet habitable may help innovate solutions to rising CO 2 . Conversion of Escherichia coli to Generate All Biomass Carbon from CO 2 Acetogenesis and the Wood-Ljungdahl pathway of CO 2 fixation Autotrophy at the thermodynamic limit of life: a model for energy conservation in acetogenic bacteria CO 2 fixation by anaerobic non-photosynthetic mixotrophy for improved carbon conversion Microbial electrosynthesis: feeding microbes electricity to convert carbon dioxide and water to multicarbon extracellular organic compounds Synergistic substrate cofeeding stimulates reductive metabolism The tiny Swiss company that thinks it can help stop climate change, The New York Times Magazine Economics of converting renewable power to hydrogen Eukaryotic microalgae as hosts for light-driven heterologous isoprenoid production A synthetic biology approach to transform Yarrowia lipolytica into a competitive biotechnological producer of b-carotene The expanding world of biosynthetic pericyclases: cooperation of experiment and theory for discovery The authors would like to thank Kristin Adolfsen, Christopher Droske, Carlos Morales-Guio, and Michel Nofal for constructive feedback. This work was supported by the UCLA Faculty Career Development Award and the Hellman Fellowship.